GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) is a Healthcare stock tracked by StreetAlpha. GEHC reports earnings on Wed, Oct 28, 2026. Analyst consensus is Buy, based on the latest ratings from 8 firms (5 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in GEHC, 0% of them bullish and 100% bearish. In the past 30 days there were 2 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 12 | BTIG | Target lowered | Buy | — |
| Oct 7 | Barclays | Initiated | Buy | — |
| Oct 5 | Citigroup | Target lowered | Hold | — |
| Sep 22 | Needham | Initiated | Buy | — |
| Aug 19 | BTIG | Reiterated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GEHC is in one of them and how their past GEHC trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GEHC in an article yet. Here's the latest on the wider market.
GEHC Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $15K – $50K | Aug 26, 2026 | Sep 22, 2026 | 27 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Aug 17, 2026 | Sep 22, 2026 | 36 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 27, 2026 | Sep 22, 2026 | 57 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 24, 2026 | Sep 22, 2026 | 60 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Jul 20, 2026 | Sep 22, 2026 | 64 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.





